Hi Gals/Guys,
I just wanted to update everyone on this Enbrel treatment for AD. I felt obligated to follow-up on this because even though the study only speaks of one patient's improvements I do think you have to consider that versus the inevitable alternative. I called the Institute of Neurological Research based of out the UCLA campus today. This Dr. Tobinick's (the study's author) place of practice, and he is also medical director of this privately held institute. I wasn't able to get many answers out of the receptionists that pick up the phone, but I can tell you the feeling I got was that they were more savvy in the art of telemarketing than they are in the knowledge of this "Tobinick Method" of Alzhiemer's treatment. In order to ask a physician any questions or determine if your loved one is eligible for this treatment of perispinal Enebril administration you must first pay a $600 telephone consultation fee to speak with Dr. Tobinick. Following the consultation you are to fly (or drive) to Los Angeles for a medical evalution of your loved one (xrays, cognitive exams, blood workup, etc.), and the cost for that first physical is $1500. The same day the first treatment is started, and followed by 6 additional treatments over a 6 week period. The cost per treatment is $600.
I've done some research on other forums and have found these numbers to be somewhat consistent across the board with $200-$300 discrepancies throughout. The patient usually needs monthly treatments after that to maintain the positive results seen after the initial 6 week treatments. After reporting this to my grandfather it seems he is interested in pursuing this. I don't blame him. When someone gives you hope for a disease in which there is no cure, you have to give it a shot. There are side-effects from this treatment, serious side-effects, and in one case a patient even died (although the cause was never determined). The only redish/yellowish flag that raises for me is the fact that Dr. Tobinick didn't report his findings from his other 16 patients that he tested. Furthermore, he didn't report a follow-up on the one patient he writes about. The study he conducted was not controlled, and there is no way of knowing whether the effects are from the drug, the route of administration, placebo (although I doubt that one), or any other factors. Lastly, he isn't a neurologist at all, he's actually a dermatologist, and an internist, and a volunteer professor with UCLA, the institute that denies any affiliation with this study. The drug manufacturer has also decided not to pursue any further research with this drug for AD use, which to me sends up a billboard-sized question mark
? After reading through this long, detailed analysis of this treatment by a few experts and critics
http://www.alzforum.org/new/detail.asp?id=1738 I am not convinced that administration of Enbrel is a "cure it all" dream potion for our loved ones. An additional study found that the Enbrel does not cross into the brain tissue, but rather only the cerebrospinal fluid. On the other hand, a study conducted by a Duke researcher found that administration of subcutaneous injections for rheumatoid arthritis led to improvements in depression and other brain related disorders. So, obviously we can't make an informed decision about what the best course of treatment would be considering the lack of evidence and thorough report on this subject. All I can say is that after reading forum posts from caregivers of those that have already received the first few treatments, I want to take my grandmother there on the next flight out.
If anyone decides to pursue this please fill us in with updates on your loved one's status, and I will do the same (depending on my grandfather's final decision). The number for INR (310) 824-6199.